Kevzara Approved for Polymyalgia Rheumatica
The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper.
The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper.
Orphenadrine citrate ER tablet is indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.
Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials.
Anecdotal reports suggest that naltrexone, an opioid antagonist, may alleviate symptoms associated with CRPS.
Three types of musculoskeletal pain and differences in diagnostic evaluation and treatment were evaluated in an in-depth systematic review to create a gold standard of care.